Why Most Minimum Annual Royalty Clauses Fail to Protect Anyone's Interests
Minimum annual royalty clauses are meant to protect universities from dormant licenses, but most are drafted in ways that undermine both parties from the start.
A. Kovacs Topic
university spinouts
18 posts tagged university spinouts from Commercializing Science.
A. Kovacs More on university spinouts
Why Most University Licensing Audit Rights Go Unexercised Until It's Too Late
Audit rights in license agreements are among the most valuable and most neglected tools in technology transfer. Here's why that keeps costing universities money.
A. KovacsWhy Most Universities Negotiate License Royalty Stacking Clauses Into Oblivion
Royalty stacking provisions look like licensee protection but often destroy deal economics. Here's what universities get wrong and how to fix it.
A. KovacsWhy Most Commercialization Readiness Reviews Happen Too Late to Matter
Most university commercialization readiness reviews are scheduled at the wrong stage, asking the wrong questions, and missing the window where intervention actually changes outcomes.
A. KovacsWhy Most Patent Priority Decisions Get Made by the Wrong People at the Wrong Time
University patent priority decisions are usually made by administrators, not commercialization strategists, and the timing guarantees bad outcomes. Here's what to fix.
A. KovacsWhy Most Reach-Through Royalty Claims Poison University-Industry Deals Before They Close
Reach-through royalty provisions look like smart IP protection but routinely kill university-industry deals. Here's what to do instead.
A. KovacsWhy Most Invention Valuation Methods Produce Numbers Nobody Actually Believes
Most invention valuation methods in tech transfer generate figures that satisfy spreadsheets but fail negotiations. Here's what actually works.
A. KovacsWhy Most Milestone Structures in License Agreements Reward the Wrong Behavior
Most license milestone structures protect universities from inaction but accidentally punish real development progress. Here's what to do instead.
A. KovacsWhy Most Patent Prosecution Strategies Ignore the Commercialization Window Entirely
Most university patent prosecution focuses on legal coverage, not commercial timing. Here's why that mismatch quietly kills licensing deals before they start.
A. KovacsWhy Most Material Transfer Agreements Quietly Kill Downstream Commercialization
MTAs look like administrative paperwork, but buried clauses routinely strip universities and startups of the IP rights they need to commercialize research.
A. KovacsWhy Most IP Assignment Clauses in Research Agreements Sabotage the Deal Later
Vague IP assignment language in sponsored research agreements creates ownership disputes that kill commercialization deals years after the science is done.
A. KovacsWhy Exclusive Licenses Destroy More Value Than They Create
Exclusive licenses feel like wins for everyone at signing. Here's why they quietly kill commercialization, and what to structure instead.
A. KovacsWhy Option Agreements Are the Most Misused Tool in Technology Transfer
Option agreements should de-risk early licensing deals, but most TTOs use them wrong. Here's what's broken and how to fix it.
A. KovacsWhy Most Invention Disclosure Forms Kill Commercialization Before It Starts
Invention disclosure forms are often the first step in tech transfer, and one of the most damaging. Here's what needs to change.
A. KovacsWhy Most Technology Readiness Level Assessments Lie to Everyone Involved
TRL scores feel objective but are routinely gamed or misread. Here's what's really happening and how to use them honestly.
A. KovacsWhy Proof-of-Concept Funding Is the Leverage Point Nobody Talks About
Proof-of-concept funding is the missing bridge between lab discovery and licensable technology, here's why most institutions underinvest in it.
A. KovacsWhy Most Licensing Term Sheets Die in Negotiation (And How to Rescue Them)
Most university licensing deals collapse not because of bad science or bad intent, but because of preventable negotiation failures. Here's what actually goes wrong.
A. KovacsWhy Corporate Venture Arms Keep Missing the Best University Deals
Corporate VCs systematically lose out on promising university spinouts due to misaligned incentives and poor deal sourcing strategies.
A. Kovacs Browse more topics